Vaginal ALK-positive anaplastic large cell lymphoma treated with brentuximab vedotin: a case report and literature review

Cortez, Anita Cassoli; Costa, Felipe D’Almeida; Silveira, Talita

doi:10.1016/j.htct.2022.01.008

Cited by 4 publications

(6 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…To our knowledge, this is the first report of ALK+ ALCL with dissemination to the gynecologic tract. Only two reports of the same histologic subtype involving the gynecologic tract appear in the literature, both of which describe primary extranodal ALK+ ALCL of the vagina [ 5 , 6 ]. The first report describes stage II disease with involvement of the bladder that initially presented as a vaginal mass in a 52-year-old with chronic renal failure.…”

Section: Discussionmentioning

confidence: 99%

“…Immunohistochemically, this case shared positive CD30 and ALK markers with our case; however, positive CD3 and negative CD43 were also present, which were the opposite findings in our case. Unfortunately, the patient deteriorated quickly and died two weeks after the initial biopsy before treatment could be initiated [ 5 , 6 ]. The second report describes stage I disease that initially presented as a vaginal lesion with associated fevers in a healthy 35-year-old.…”

Section: Discussionmentioning

confidence: 99%

“…Immunohistochemistry was positive for CD4, CD43, CD30, and ALK, identical to our case. The patient had a complete response to treatment with systemic chemotherapy (BV-CHP) as of one-year follow-up [ 6 ]. The patient’s outcome beyond this time is unknown.…”

Section: Discussionmentioning

confidence: 99%

“…Herein, we describe a case of anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma (ALK+ ALCL) with secondary involvement of the uterus and cervix successfully treated with systemic chemotherapy. Only two cases of the same histologic subtype involving the gynecologic tract have been reported to date, both of which describe primary disease of the vagina [ 5 , 6 ].…”

Section: Introductionmentioning

confidence: 99%

“…The majority of cases are of B-cell origin, with diffuse large B-cell lymphoma (DLBCL) being the most common histologic subtype [1,3]. T-cell lymphomas involving the gynecologic tract are far less common and typically have a poor prognosis [1][2][3][4][5][6][7]. Herein, we describe a case of anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma (ALK+ ALCL) with secondary involvement of the uterus and cervix successfully treated with systemic chemotherapy.…”

Section: Introductionmentioning

confidence: 99%

See 4 more Smart Citations

Disseminated Anaplastic Lymphoma Kinase (ALK)-Positive T-cell Lymphoma Involving the Uterus and Cervix: A Case Report

Yang,

Sabri,

Awad

et al. 2024

Cureus

View full text Add to dashboard Cite

Primary or secondary non-Hodgkin lymphomas (NHLs) involving the female gynecologic tract are rare. T-cell subtypes are further rare and portend a worse prognosis. We present a case of a 23-year-old female presenting with a cervical mass accompanied by constitutional symptoms and abnormal vaginal bleeding. Immunohistochemistry studies revealed the presence of disseminated T-cell non-Hodgkin lymphoma that was anaplastic lymphoma kinase (ALK)-positive. The patient demonstrated a complete response to systemic chemotherapy initially and again after the relapse of the disease one year after diagnosis. To our knowledge, this is the first case of an ALK-positive T-cell lymphoma with secondary involvement of the uterus and cervix; all previously published cases of this histologic subtype in the gynecologic tract describe primary disease of the vagina. This case emphasizes the importance of immunohistochemistry studies inclusive of T-cell and B-cell markers when evaluating biopsies from cervical tumors to render the appropriate diagnosis and guide systemic therapy.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Disseminated Anaplastic Lymphoma Kinase (ALK)-Positive T-cell Lymphoma Involving the Uterus and Cervix: A Case Report

Yang,

Sabri,

Awad

et al. 2024

Cureus

View full text Add to dashboard Cite

show abstract

Superior prognostic accuracy of FIGO staging system in primary female genital tract lymphomas: A retrospective study (IELSG35)

Pirosa,

Steffanoni,

Vanazzi

et al. 2024

Hematological Oncology

View full text Add to dashboard Cite

Primary lymphoma of the female genital tract (PLFGT) is a rare type of extranodal lymphoma. In this retrospective study from the International Extranodal Lymphoma Study Group, we analyzed clinical data from 60 women diagnosed with PLFGT between 1982 and 2012. The median age was 52 years. Limited stage, as defined by the Ann Arbor and FIGO staging systems, was observed in 55% and 63% of cases, respectively. The uterus was the primary site of lymphoma in 25 cases, with the ovaries as the second most common site (n = 24). The most common histological subtype was diffuse large B‐cell lymphoma (DLBCL, n = 44), followed by follicular lymphoma and marginal zone lymphoma (6 patients each). Two patients received surgery alone as first‐line therapy, while 58 underwent systemic therapy, 16 following major surgery. Thirteen patients received consolidation radiotherapy and six were given central nervous system (CNS) prophylaxis. Twenty patients had disease progression or recurrence. Six patients with DLBCL (14%) experienced CNS relapse, which was the only site of recurrence in five of them. All but one patient with CNS relapse had primary ovarian involvement, and three had bulky disease; none of these patients had received CNS prophylaxis. With a median follow‐up of 60 months, the median overall survival of the DLBCL cohort was approximately 13 years, with a 5‐year survival rate of 77%. In multivariable analysis, advanced disease according to the FIGO system was the only parameter significantly associated with shorter overall, cause‐specific, and progression‐free survival in patients with DLBCL.

show abstract

Anaplastic large cell lymphoma presenting as a mass in the uterine cervix: a case report

Mingola,

Alshomrani,

Greiner

2023

J Hematopathol

View full text Add to dashboard Cite

Vaginal ALK-positive anaplastic large cell lymphoma treated with brentuximab vedotin: a case report and literature review

Cited by 4 publications

References 8 publications

Disseminated Anaplastic Lymphoma Kinase (ALK)-Positive T-cell Lymphoma Involving the Uterus and Cervix: A Case Report

Disseminated Anaplastic Lymphoma Kinase (ALK)-Positive T-cell Lymphoma Involving the Uterus and Cervix: A Case Report

Superior prognostic accuracy of FIGO staging system in primary female genital tract lymphomas: A retrospective study (IELSG35)

Anaplastic large cell lymphoma presenting as a mass in the uterine cervix: a case report

Contact Info

Product

Resources

About